ANGELINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 7.057
AS - Asia 4.135
EU - Europa 2.854
SA - Sud America 487
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 14.634
Nazione #
US - Stati Uniti d'America 6.958
CN - Cina 1.219
SG - Singapore 1.219
IT - Italia 935
VN - Vietnam 660
BR - Brasile 389
DE - Germania 338
HK - Hong Kong 317
PL - Polonia 249
UA - Ucraina 241
IE - Irlanda 224
JP - Giappone 143
GB - Regno Unito 137
FR - Francia 132
KR - Corea 131
RU - Federazione Russa 127
AT - Austria 126
SE - Svezia 121
IN - India 98
TR - Turchia 68
ID - Indonesia 47
AR - Argentina 45
CA - Canada 45
FI - Finlandia 41
PK - Pakistan 40
CH - Svizzera 36
MX - Messico 36
NL - Olanda 31
IQ - Iraq 30
BD - Bangladesh 29
ES - Italia 29
BE - Belgio 26
PH - Filippine 21
ZA - Sudafrica 17
TH - Thailandia 15
UZ - Uzbekistan 14
VE - Venezuela 14
EC - Ecuador 13
MA - Marocco 13
CL - Cile 12
BJ - Benin 11
TW - Taiwan 11
JO - Giordania 10
SA - Arabia Saudita 10
KE - Kenya 9
PT - Portogallo 9
AU - Australia 7
OM - Oman 7
AZ - Azerbaigian 6
DK - Danimarca 6
EG - Egitto 6
EU - Europa 6
GR - Grecia 6
IR - Iran 6
LB - Libano 6
LT - Lituania 6
AL - Albania 5
CO - Colombia 5
DZ - Algeria 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
NP - Nepal 4
RO - Romania 4
SY - Repubblica araba siriana 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
SN - Senegal 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
ME - Montenegro 2
MT - Malta 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CU - Cuba 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
Totale 14.614
Città #
Ashburn 974
Woodbridge 711
Fairfield 690
Singapore 682
Chandler 417
Jacksonville 356
San Jose 336
Seattle 319
Hong Kong 292
Houston 280
Ann Arbor 250
Warsaw 238
Cambridge 228
Wilmington 224
Dublin 217
New York 196
Dallas 184
Ho Chi Minh City 180
Hanoi 163
Beijing 158
Council Bluffs 128
Seoul 114
Venice 114
Los Angeles 112
Mestre 112
Vienna 106
Nanjing 104
Boardman 101
Tokyo 99
Jinan 91
Venezia 82
Shenyang 67
Dearborn 66
Milan 62
Boston 59
Hefei 59
Guangzhou 55
Lauterbourg 55
San Mateo 51
Mülheim 50
Santa Clara 49
Andover 45
Tianjin 45
Princeton 44
Frankfurt am Main 42
Munich 42
Izmir 41
Hebei 40
São Paulo 40
Jakarta 38
London 35
San Diego 35
Padova 33
Bengaluru 31
Columbus 31
Nuremberg 31
Taiyuan 31
Buffalo 30
Ningbo 30
Chicago 29
Orem 29
Hangzhou 28
San Paolo di Civitate 28
Zhengzhou 28
The Dalles 27
Changsha 26
Haiphong 26
Taizhou 25
Helsinki 24
Da Nang 23
Moscow 23
Verona 21
Altamura 20
Chennai 19
Toronto 19
Nanchang 18
Treviso 18
Multan 17
Redondo Beach 17
Redwood City 17
Brussels 16
Fuzhou 16
Pune 15
Saint Petersburg 15
Vittorio Veneto 15
Amsterdam 14
Denver 14
Bremen 13
Haikou 13
Jiaxing 13
Rio de Janeiro 13
Hải Dương 12
Shanghai 12
Atlanta 11
Berlin 11
Biên Hòa 11
Brooklyn 11
Cotonou 11
Kilburn 11
Amman 10
Totale 10.234
Nome #
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis 537
Structurally diverse cyclisation linkers impose different backbone conformations in bicyclic peptides 476
Covalent immobilization of delipidated human serum albumin on poly(pyrrole-2-carboxylic) acid film for the impedimetric detection of perfluorooctanoic acid 404
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses 386
Molecular evolution of peptides by yeast surface display technology 367
Protein engineering and selection using yeast surface display 365
Bicyclic Peptides Conjugated to an Albumin-Binding Tag Diffuse Efficiently into Solid Tumors 361
Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics 349
Enzymatic Cyclisation of Peptides with a Transglutaminase 338
Triggering positive selection of germinal center B cells by antigen targeting to DEC-205 331
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2 321
Chemical Macrocyclization of Peptides Fused to Antibody Fc Fragments 307
Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target 289
Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists 289
Nanocoated fiber label-free biosensing for perfluorooctanoic acid detection by lossy mode resonance 282
Inibitori peptidici biciclici dell’attivatore del plasminogeno di tipo urochinasi umana (huPA) 279
Measuring net protease activities in biological samples using selective peptidic inhibitors 278
Crystal structure of CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for a type IV secretion system 271
Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases 271
Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting 270
Boosting the Sensitivity of Ligand-Protein Screening by NMR of Long-Lived States 260
Genetically Encoded Synthetic Polypeptides as Innovative Cancer Therapeutics 258
Expression of Helicobacter pylori CagA domains by library-based construct screening 257
Unveiling the binding mode of perfluorooctanoic acid to human serum albumin 257
Thiol-to-amine cyclization reaction enables screening of large libraries of macrocyclic compounds and the generation of sub-kilodalton ligands 247
Macrocycle synthesis strategy based on step-wise "adding and reacting" three components enables screening of large combinatorial libraries 246
The Helicobacter pylori CagD (HP0545, Cag24) Protein Is Essential for CagA Translocation and Maximal Induction of Interleukin-8 Secretion 243
Peptide Ligands Stabilized by Small Molecules 241
Structural Biology of Helicobacter pylori type IV secretion system 240
Structurally Diverse Cyclisation Linkers Impose Different Backbone Conformations in Bicyclic Peptides 238
Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor 234
Native mass spectrometry for the design and selection of protein bioreceptors for perfluorinated compounds 234
Bicyclic peptide-based assay for uPA cancer biomarker 233
Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds 215
Structural and mutational analysis of TenA protein (HP1287) from the Helicobacter pylori thiamin salvage pathway - evidence of a different substrate specificity 212
A novel genetically-encoded bicyclic peptide inhibitor of human urokinase-type plasminogen activator with better cross-reactivity toward the murine orthologue 207
Phage display libraries of differently sized bicyclic peptides 206
Post-translational modification of genetically encoded polypeptide libraries 206
Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil 204
Guidelines, Strategies, and Principles for the Directed Evolution of Cross-Reactive Antibodies Using Yeast Surface Display Technology 204
An Impedimetric Biosensing Strategy Based on Bicyclic Peptides as Bioreceptors for Monitoring huPA Cancer Biomarker 190
Combination of Coevolutionary Information and Supervised Learning Enables Generation of Cyclic Peptide Inhibitors with Enhanced Potency from a Small Data Set 189
Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions 183
Multiple specificity binders of CXC chemokines and uses thereof 181
The crystal structure of CagS from the Helicobacter pylori pathogenicity island 171
Single cells from human primary colorectal tumors exhibit polyfunctional heterogeneity in secretions of ELR plus CXC chemokines 164
Towards the understanding of molecular aspects of Helicobacter pylori cag-PAI 164
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription 164
Generation of a selective urokinase-type plasminogen activator (uPA) inhibitor based on a bicyclic peptide 161
Crystal structure of human serum albumin in complex with megabody reveals unique human and murine cross‐reactive binding site 160
Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking 149
Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy 147
Challenges and Achievements of Peptide Synthesis in Aqueous and Micellar Media 142
Quantitative Affinity Screening of Macrocyclic Peptide Libraries Using Yeast Surface Display Technology 140
Development and characterization of a latex turbidimetric immunoassay using rabbit anti-CRP single-chain Fv antibodies 140
Structural and enzymatic characterization of HPO496, a YbgC thioesterase from Helicobacter pylori 137
Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA 136
Albumin-based strategies to effectively prolong the circulation half-life of small immunomodulatory payloads in cancer therapy 133
Development of a novel and broadly applicable sandwich ELISA assay based on rabbit single-chain variable fragments and a modified Ig-binding domain of protein L fused to a polystyrene-binding peptide 131
In Vitro Binding Analysis of Legacy-Linear and New Generation-Cyclic Perfluoro-Alkyl Substances on Sex Hormone Binding Globulin and Albumin, Suggests Low Impact on Serum Hormone Kinetics of Testosterone 106
Nanobodies targeting LexA autocleavage disclose a novel suppression strategy of SOS-response pathway 102
Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation 94
Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale 89
Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cells 54
Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2 14
Totale 14.854
Categoria #
all - tutte 47.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021482 0 0 0 0 0 0 0 0 0 154 224 104
2021/20221.406 130 204 120 149 85 12 58 39 24 173 262 150
2022/20231.450 123 154 56 87 181 378 27 101 161 23 119 40
2023/2024850 35 44 38 41 79 206 34 83 70 37 98 85
2024/20251.537 31 45 154 156 159 110 148 163 164 134 175 98
2025/20264.911 418 273 444 409 676 444 844 277 659 467 0 0
Totale 14.854